EMA starts rolling review of COVID-19 Vaccine HIPRA EMA’s human medicines committee (CHMP) has started a rolling review of COVID-19 Vaccine HIPRA (also known as PHH-1V). This protein-based vaccine is being developed by HIPRA Human Health S.L.U. as a booster vaccine for adults who have already been fully vaccinated with a different COVID-19 vaccine. The CHMP’s … Continue reading COVID-19 Patients in Hospitals and Vaccination and in Europe